AXAxinet
Menu
Finance

Live market screen

Commercial Space Company Risk / Opportunity Ranking

Opportunity/risk view across launch, satellites, SAR, earth observation, defense demand, financing events, and execution risk.

Updated June 27, 2026

Companies analyzed
438
Ranked rows
876
Evidence links
356
Rows per page
20

Opportunity view

Showing rows 361-380 of 438; 20 rows per page.

Sorted by raw opportunity score
RankCompanyScoreThesis / Evidence
361
Romanian InSpace Engineering
lowweak
Opp 1
Risk 1

Thesis: The reviewed sources only provides older membership context that Romanian InSpace Engineering was part of the consortium that developed the EMISAR satellite via article; that is insufficient for a current positive thesis within this ranking window.

Why now: No why-now catalyst is evidenced because there are no retained 90-day evidence.

Caveats: Reviewed evidence references but provides no. Single historical membership-support mention only. No retained evidence after recent evidence window.

362
Safran
lowweak
Opp 1
Risk 1

Thesis: The reviewed sources does not provide direct positive company-specific evidence within the available 90-day evidence set. Only older or contextual references are cited in the membership rationale, including thematic propulsion or battery market reports and a reference to expanded small-satellite propulsion manufacturing, but no direct post-recent evidence window evidence is available for scoring.

Why now: There is no current catalyst in the reviewed sources. Coverage debug shows 270 article IDs considered but 0 article IDs after recent evidence window and 0 evidence available after dedupe, so recency-based thesis formation is not supported.

Caveats: Membership rationale references article IDs 2026-04, and, but no are provided in the reviewed sources, so they cannot be cited as factual scoring evidence under the the evidence standard. Evidence recent evidence review shows 0 kept rows after the 90-day cutoff.

363
SatLeo Labs
lowweak
Opp 1
Risk 1

Thesis: Reviewed evidence rationale says SatLeo Labs raised seed funding for a multispectral and thermal Earth observation constellation, but no retained article/evidence are available here to support a stronger opportunity ranking.

Why now: No retained within the recent evidence window evidence are provided, so there is no reviewed sources-supported why-now beyond cohort inclusion rationale.

Caveats: Only membership rationale is available; no citeable retained evidence. Small-company universe but zero available evidence after recent evidence window.

364
SciTec
lowweak
Opp 1
Risk 1

Thesis: The reviewed sources say AI software came from a SciTec subsidiary in connection with Firefly's lunar imaging service, but this is only supporting article context without retained direct evidence, so it does not support a strong long-horizon opportunity thesis for SciTec itself.

Why now: No current catalyst is established because the reviewed sources retains no company-specific evidence after the 90-day filter.

Caveats: Phase-2 rationale references, but no or retained summary is available in the reviewed sources. Support level is provisional single-article context. No direct company-specific positive or negative evidence remain after recent evidence window.

365
SEALSQ Corp
lowweak
Opp 1
Risk 2

Thesis: Reviewed evidence membership rationale says SEALSQ is directly involved with WISeSat in a planned 100-satellite QSOC constellation and post-quantum satellite launches, which could indicate long-horizon strategic relevance, but no usable direct positive evidence or article survive the 90-day served evidence set in these reviewed sources.

Why now: Why now is weak because the 90-day reviewed sources contain no available evidence after recent evidence window for SEALSQ, despite article history existing in the broader corpus.

Caveats: No direct positive or negative evidence available after recent evidence window. Membership rationale references article IDs and, but the reviewed sources provide no for them, so they cannot be cited as factual support under the the evidence standard.

366
SEALSQ Corp
lowweak
Opp 1
Risk 1

Thesis: Reviewed evidence context links SEALSQ to post-quantum payload development with WISeSat, but there is no retained direct positive evidence inside the 90-day recent evidence window to support a 1 year+ opportunity thesis.

Why now: There is no usable current evidence because articles after recent evidence window = 0 and evidence after recent evidence window = 0 following the March 29, 2026 cutoff.

Caveats: No surviving recent evidence window-qualified evidence. Space relevance in reviewed sources rationale does not establish direction.

367
SES S.A.
lowweak
Opp 1
Risk 1

Thesis: The reviewed sources membership rationale places SES in satellite communications and infrastructure contexts, but there are no available within the recent evidence window evidence or article details to support a directional opportunity thesis for this screen.

Why now: Why-now is weak because no reviewed evidence are available after recent evidence window, so recency and catalysts cannot be assessed from the reviewed sources.

Caveats: Membership rationale references and, but no corresponding available article summaries or evidence are provided. Coverage debug shows articles after recent evidence window 0 and evidence after recent evidence window 0. Cohort membership does not establish opportunity.

368
Sidus Space Inc.
lowweak
Opp 1
Risk 1

Thesis: The reviewed sources' membership rationale references payload and agreement expansion activity, but no retained within the recent evidence window direct evidence or article summaries are available here to support a positive investment-style thesis.

Why now: There is no retained dated company evidence after the 90-day recent evidence window; timing support for a 1 year+ thesis is absent in the reviewed sources.

Caveats: Coverage is effectively empty after recent evidence window: articles after recent evidence window = 0 and evidence after recent evidence window = 0. The membership rationale mentions article IDs, and, but no or retained evidence content are provided in these reviewed sources.

369
SkyFi
lowweak
Opp 1
Risk 1

Thesis: No direct positive evidence is available, so there is no supportable upside thesis from these reviewed sources alone.

Why now: Membership rationale says SkyFi was mentioned as a commercial access partner for Vantor's satellite imagery constellation in article, but this is only contextual and no or direct evidence are provided.

Caveats: Partner context is weaker than direct company evidence. No evidence available after recent evidence filtering. Referenced has no in the reviewed sources.

370
Skyfora
lowweak
Opp 1
Risk 1

Thesis: The reviewed sources only says Skyfora appears in a funding roundup with a €6.5M raise, but no retained direct evidence or article summaries are provided after the 90-day recent evidence window, so there is not enough evidence to support a positive 1 year+ thesis.

Why now: No within the recent evidence window company-specific catalyst is provided. The reviewed sources reports zero reviewed evidence after the 90-day cutoff for Skyfora, so recency is insufficiently grounded.

Caveats: Phase-2 rationale references a €6.5M raise tied to: but no representative article, or retained evidence row is provided in these reviewed sources, so it cannot be used as direct scored evidence. Coverage debug shows articles after recent evidence window = 0 and evidence after recent evidence window = 0. Membership review status is not directional proof.

371
Solestial Inc.
lowweak
Opp 1
Risk 1

Thesis: No positive thesis is supportable from these reviewed sources because no retained direct positive evidence is provided inside the recent evidence window.

Why now: No current catalyst can be established from the reviewed sources; the company has zero evidence after recent evidence window.

Caveats: Phase-2 rationale says York Space Systems acquired Solestial and cites: but no article summary or is provided here, so it cannot be used as cited factual support. Coverage debug shows 4 articles considered and 0 article IDs after recent evidence window. Absence of evidence is not positive or negative proof.

372
Solstar Space Company
lowweak
Opp 1
Risk 1

Thesis: The membership rationale says Solstar's Deke Space Communicator operated in orbit and achieved TRL 9 with two-way data transmission and onboard Wi-Fi, which could imply commercialization potential, but no direct positive evidence or article summaries are available for scoring in these reviewed sources.

Why now: The reviewed sources contain no reviewed evidence after recent evidence window for this company, preventing a recency-based 1 year+ ranking judgment beyond watchlist status.

Caveats: Membership rationale references article, but no direct summary or evidence row is available here for citation. Coverage debug shows zero available evidence after recent evidence window. Private-company status is not itself positive or negative.

373
Space Systems/Loral, LLC (SSL)
lowweak
Opp 1
Risk 1

Thesis: SSL is referenced in membership rationale as appearing among key players in an optical satellite market report, but that is only article-level industry context and no direct within the recent evidence window evidence is available.

Why now: No current catalyst can be established because coverage debug shows 0 article IDs after recent evidence window and 0 evidence after recent evidence window. The rationale cites: without a in these reviewed sources.

Caveats: Only industry-report context is referenced in membership rationale. No direct event/fact evidence survived the recent evidence window.

374
Space42
lowweak
Opp 1
Risk 1

Thesis: Space42 is described in membership rationale as operating a SAR Earth observation constellation with satellites entering full operation, but the reviewed sources retains no direct evidence or article summaries within the recent evidence window to support a current opportunity ranking.

Why now: Why now is weak because coverage data shows no articles after recent evidence window and no evidence after recent evidence window.

Caveats: Membership rationale references article IDs but no are provided, so they cannot be used as cited factual support here. Coverage debug shows articles after recent evidence window 0 and evidence after recent evidence window 0.

375
SpaceLocker
lowweak
Opp 1
Risk 1

Thesis: There is not enough retained evidence in the recent evidence window to underwrite a durable opportunity case, despite membership rationale describing a first shared satellite mission.

Why now: No article-level or event-level evidence were retained after the March 29, 2026 recent evidence window cutoff; recency for the membership rationale is therefore unusable for ranking.

Caveats: Membership rationale references article, but no representative article summary or retained evidence row is included. Single-article universe with zero retained rows limits confidence materially.

376
SpaceLogistics (Northrop Grumman)
lowweak
Opp 1
Risk 2

Thesis: The reviewed sources contain a descriptive article saying SpaceLogistics provides cooperative in-orbit satellite servicing using commercial servicing vehicles, which supports strategic relevance as a business category, but the only cited article is dated March 4, 2025 and was dropped by the 90-day recent evidence window.

Why now: Why now is weak because the only cited article, March 4, 2025), falls outside the 90-day recent evidence window and was dropped; recency therefore does not support an active thesis here.

Caveats: No evidence were kept after recent evidence filtering. Cannot rely on dropped 2025 evidence for a current ranking. Company-category relevance is not sufficient for a directional opportunity thesis.

377
Spaceworks
lowweak
Opp 1
Risk 1

Thesis: The reviewed sources only says Momentus's fully booked Vigoride 8 mission will carry a Spaceworks COSMIC payload, which indicates some space-payload involvement but does not establish a durable company-specific opportunity thesis for Spaceworks.

Why now: No within the recent evidence window retained catalyst is available. The phase-2 rationale references, but no, timestamp, or retained summary is included.

Caveats: Support is provisional single-article context only. No retained direct evidence after recent evidence window. Payload mention does not prove company-level commercial traction.

378
Spacium
lowweak
Opp 1
Risk 2

Thesis: Spacium has a potentially attractive refueling/logistics angle, and an older article says it raised an oversubscribed $6.3 million seed round, but that dated evidence is outside the 90-day recent evidence window and therefore cannot support a current-ranked opportunity thesis.

Why now: The only cited article is dated January 23, 2025, and the reviewed sources explicitly shows it was dropped by the 90-day recent evidence window cutoff of March 29, 2026.

Caveats: All dated evidence was excluded by recent evidence window. Do not use out-of-window article as current recency proof.

379
SSC Space
lowweak
Opp 1
Risk 1

Thesis: No positive thesis is supportable from these reviewed sources because no direct positive evidence remains after recent evidence filtering.

Why now: There is no retained within the recent evidence window evidence for a current catalyst.

Caveats: Phase-2 rationale mentions a sponsored article and a partnership supporting Firefly's Blue Ghost lunar lander antennas, citing, but no or article summary is provided in these reviewed sources. Coverage debug shows 3 articles considered and 0 after recent evidence window. Sponsored-article context would be weaker than direct event/fact evidence even if fully provided.

380
ST Engineering
lowweak
Opp 1
Risk 1

Thesis: Only weak, supporting article context suggests ST Engineering had involvement in SAR and AI geospatial analytics for satellite ocean surveillance, but the reviewed sources contain no direct positive evidence after the 90-day recent evidence window and no article to substantiate a durable 1 year+ opportunity thesis (: not provided in reviewed sources).

Why now: There is no usable dated direct evidence inside the recent evidence window; the reviewed sources explicitly shows articles after recent evidence window = 0 and evidence after recent evidence window = 0, so recency-based timing is unsupported.

Caveats: No direct evidence remained after the recent evidence filter. Representative articles are empty, so no is available in the reviewed sources. Membership rationale is weaker than company-specific event evidence.

Risk view

Showing rows 161-180 of 438; 20 rows per page.

Sorted by raw risk score
RankCompanyScoreThesis / Evidence
161
HawkEye 360, Inc.
lowweak
Opp 2
Risk 2

Thesis: The reviewed sources lack direct positive or negative company-specific in-window operating evidence; the only retained article is weak supporting article context. That makes both upside and downside hard to validate, and uncertainty itself is the main risk.

Why now: The only retained dated item is an April 5, 2026 supporting article context entry stating HawkEye 360 is a data analytics company developing space-based radio frequency mapping and a satellite constellation startup: That is too weak to establish a strong current catalyst.

Caveats: Only weak supporting article context is retained after recent evidence window; no direct event/fact evidence is available. Phase2 rationale mentions 30+ satellites and government contracts, but the reviewed sources does not provide those source articles in detail here.

162
HEO
lowweak
Opp 3
Risk 2

Thesis: Risk is mainly evidentiary: the reviewed sources lack direct dated operating, financing, execution, or customer-conversion evidence, so business durability and current momentum are unclear.

Why now: Why now is weak because both cited items are undated, so the reviewed sources does not establish a fresh catalyst within the current evidence window. The only support is that HEO appears in current reviewed sources context as an operating company and as associated with a contract mention, but recency cannot be confirmed from the reviewed sources

Evidence
  • Space Index lists HEO in 'In-Orbit Servicing & Assembly Companies' with status 'operating'; article is undated. spaceindex.io
  • Undated article summary says: 'BlackSky Signs Seven-Figure Space Domain Awareness Expansion Contract with HEO for Fully Automated Non-Earth Imaging Missions.' talksatellite.com

Caveats: Both supporting items are undated, so recency is uncertain. Support is supporting article context, not stronger company-specific dated event evidence. Same-article repeated rows in the reviewed sources are not independent confirmation.

163
Hispasat
lowweak
Opp 4
Risk 2

Thesis: The reviewed sources does not provide retained in-window article detail on contract economics, implementation timing, or execution risk, so the business significance cannot be scored aggressively and no direct adverse evidence is shown.

Why now: The only timing clue is the membership rationale referencing article, but the underlying article summary and are not included in these reviewed sources. Recency beyond the batch month label is uncertain.

Caveats: No representative article or is available in the reviewed sources despite the favorable rationale. Program-role evidence can be important, but without economics or milestones the opportunity case is incomplete.

164
HughesNet
lowweak
Opp 1
Risk 2

Thesis: Risk is mostly evidence absence rather than confirmed adverse developments: despite 104 considered articles, the reviewed sources loads zero direct negative or positive rows after recent evidence window, leaving business-state, financing, competitive, and operational risks unresolved.

Why now: There is no validated near-term or long-term catalyst from active evidence. The reviewed sources cites article in membership support, but the company coverage section shows zero articles after recent evidence window and zero evidence after recent evidence window, so recency-backed thesis formation is not possible.

Caveats: High article count does not equal conviction; no post-recent evidence window evidence was available. No direct company-specific event/fact evidence is available in the output reviewed sources.

165
Institute for Q-shu Pioneers of Space, Inc (iQPS)
lowweak
Opp 3
Risk 2

Thesis: No direct negative evidence is available. Residual risk comes from limited evidence depth in the ranking reviewed sources and the lack of direct operating, financing, or customer traction details after recent evidence window.

Why now: Why now is only modest because launch-linked deployment could matter over a long horizon, but there are no available article summaries or dated events to establish current momentum.

Caveats: Membership rationale references article IDs and, but no or summaries are provided. No direct evidence survived or were available into these reviewed sources after recent evidence window. Do not use relation context as counterparty propagation evidence.

166
Intelsat General
lowweak
Opp 2
Risk 2

Thesis: No material adverse evidence is available in the local reviewed sources, but absence of current direct evidence also prevents a strong positive thesis.

Why now: Why-now support is weak because coverage data shows zero article/evidence after the 90-day recent evidence window, so recency for the cited contract context cannot be validated from available evidence.

Caveats: Phase2 membership rationale references: but no representative article or evidence row is available after recent evidence window for direct citation. Coverage data reports articles after recent evidence window = 0 and evidence after recent evidence window = 0. Scored low due to evidence absence, not due to negative business evidence.

167
Jacobs
lowweak
Opp 2
Risk 2

Thesis: There is no material adverse evidence. Risk is low-to-moderate only because current reviewed sources evidence is stale for the selected recent evidence window, not because of a negative event.

Why now: Why now is weak because the contract evidence is older. The reviewed sources cites Space Force and SpaceNews articles dated June 3, 2025, which are outside the 90-day evidence window

Caveats: Contract evidence exists but falls outside the selected 90-day recent evidence window. No direct positive or negative evidence remain after recent evidence filtering.

168
Jio Platforms
lowweak
Opp 2
Risk 2

Thesis: Because the reviewed sources frames Jio's satellite effort as planned and early-stage, execution and timing risk are meaningful, but the reviewed sources still lacks direct adverse evidence to score risk highly.

Why now: Why now is not well supported in the served evidence because no representative articles or direct evidence are available after recent evidence window despite the membership rationale referencing article IDs, and

Caveats: No representative articles or direct evidence are included in the reviewed sources output. Membership rationale is not a substitute for direct thesis evidence. Recency and event sequence cannot be judged from the missing article details.

169
K2 Space
mediummedium
Opp 5
Risk 2

Thesis: The main risk is evidence quality rather than a documented adverse event: the reviewed sources classifies the available support as weak supporting article context with neutral polarity and no direct positive or negative dated event/facts, limiting confidence in both upside magnitude and downside assessment.

Why now: The evidence is recent within the 90-day recent evidence window and dated June 11, 2026 on a source date basis, which fits a 1 year+ horizon because supplier-role wins in defense satcom can matter over a longer program cycle if they convert into execution and revenue-bearing milestones.

Evidence
  • June 11, 2026: SpaceNews summary says K2 Space and Rocket Lab 'have landed key supplier roles' in the U.S. Space Force's next-generation military communications network, and K2 Space 'will provide the satellite platform for SES’s entry' in PTS-G. spacenews.com

Caveats: Available support is supporting article context with neutral polarity, not direct structured positive event/fact evidence. Only one dated article remains within the recent evidence window; same-article repeated rows are not independent confirmation.

170
Kepler Communications
lowweak
Opp 3
Risk 2

Thesis: Opportunity remains speculative because the reviewed sources offers only contextual support and no available company-specific event or fact evidence after recent evidence window; customer traction, contract value, deployment status, and monetization are not confirmed.

Why now: The reviewed sources references, and: in membership support, suggesting recent strategic context, but no post-recent evidence window evidence are actually available for scoring.

Caveats: Reviewed evidence itself says support is somewhat contextual. Context-only references are weaker than direct event/fact evidence. No available evidence confirms deployment, revenue, or funding milestones.

171
Korea Aerospace Industries (KAI)
lowweak
Opp 2
Risk 2

Thesis: No material adverse evidence is present in the reviewed sources. Risk is low-to-moderate only because the evidence set is empty after recent evidence window, so there is insufficient support for either a strong positive or negative thesis.

Why now: Why now is weak because the reviewed sources say one article supported membership, article ID: but no, timing detail, or direct evidence were available after recent evidence window.

Caveats: No direct evidence or article summaries were available after recent evidence window. Membership support references article ID: without a in the reviewed sources.

172
LiveEO
lowweak
Opp 3
Risk 2

Thesis: No direct negative evidence is provided; risk is mainly that the thesis is under-evidenced in these reviewed sources.

Why now: Why-now cannot be established because no evidence remain after recent evidence filtering.

Caveats: Phase2 membership rationale references, but no summary or evidence are provided for citation. Coverage debug shows articles after recent evidence window = 0 and evidence after recent evidence window = 0. Low scores reflect missing usable evidence, not a bearish business judgment.

173
Lockheed Martin
mediummedium
Opp 6
Risk 2

Thesis: The reviewed sources show no direct adverse evidence within the recent evidence window; main risk is that the support here is only supporting article context rather than stronger direct event/facts.

Why now: The relevant contract article is dated April 16, 2026, inside the 90-day recent evidence window, and describes current modernization work tied to GPS IIIF support, which can matter over a multi-quarter horizon. Source date: April 16, 2026

Evidence
  • The U.S. Space Force awarded Lockheed Martin a contract worth up to $105 million to modernize its GPS ground control network and support launch, early orbit, and disposal operations for GPS IIIF satellites. April 16, 2026. morningstar.com

Caveats: Evidence is supporting article context only; no direct positive event row is available. Same article appears in multiple weak-context rows and does not count as independent confirmation.

174
Lockheed Martin Corporation
lowweak
Opp 2
Risk 2

Thesis: No material adverse evidence is available in these reviewed sources, but the absence of current direct evidence prevents a strong positive ranking.

Why now: There is no available why-now evidence within the 90-day recent evidence window; coverage data shows zero evidence after recent evidence window.

Caveats: Phase2 rationale cites, and, but no representative articles or evidence are available in the reviewed sources body for citation. Coverage data reports articles after recent evidence window = 0 and evidence after recent evidence window = 0. Low score reflects insufficient current reviewed sources evidence, not a negative fundamental view.

175
LSS GmbH
lowweak
Opp 1
Risk 2

Thesis: Primary risk is evidentiary: the reviewed sources does not establish current business traction, financial position, or recent contract progress for LSS GmbH within the recent evidence window, so any positive thesis is highly speculative.

Why now: There is no clear 'now' catalyst in the available evidence. The reviewed sources states zero article IDs after recent evidence window and zero evidence available after recent evidence window, so recency is unverified for a 1 year+ ranking.

Caveats: Phase-2 rationale references consortium work tied to: and: but the reviewed sources does not include article summaries or for those items. Coverage debug shows zero evidence after recent evidence window, so no direct claim can be validated as current. Cohort review status is not a directional signal.

176
Lux Aeterna
lowweak
Opp 2
Risk 2

Thesis: Early-stage hardware execution risk is plausible, but the reviewed sources does not provide direct negative evidence inside the recent evidence window, so risk should remain low-scored.

Why now: No within the recent evidence window evidence were retained for ranking, so there is no evidence-backed near-term or durable timing edge beyond generic early-stage company progress assumptions.

Caveats: Membership rationale references article: but the reviewed sources does not include its or a retained evidence row.

177
Lynk Global, Inc.
lowweak
Opp 2
Risk 2

Thesis: The reviewed sources does not describe the business model directly, so assessment risk is high; no material adverse event evidence is available after recent evidence filtering.

Why now: If a rideshare payload mention reflects program progress, that could matter over 1 year+, but the reviewed sources provide no citable event details, timestamps, quote, or for article ids: and

Caveats: A payload mention is more concrete than generic context, but still insufficient here because no direct evidence row or citation is included. No recent evidence window-surviving evidence exists in the reviewed sources. Slight score uplift reflects somewhat more operationally concrete context only.

178
Mach Industries
lowweak
Opp 3
Risk 2

Thesis: The same rationale also implies category ambiguity: the company is presented primarily as defense tech, so the space thesis may be overstated. No direct adverse event is available; risk is mostly execution and classification uncertainty rather than reviewed sources-proven negative developments (: not provided in reviewed sources).

Why now: For a 1 year+ horizon, a large raise and mention of a satellite platform could matter if recent, but the reviewed sources does not provide usable dated evidence within the 90-day recent evidence window and explicitly reports zero available evidence after recent evidence window.

Caveats: No article provided in reviewed sources. No direct event/facts are available after recent evidence window despite the membership rationale referencing a raise. Primarily defense-tech framing may limit pure-play space thesis relevance.

179
Maxar Technologies Inc.
lowweak
Opp 3
Risk 2

Thesis: Risk is mostly evidence-gap risk in these reviewed sources: without retained 90-day evidence, there is no current confirmation of contract timing, backlog conversion, program execution, or adverse developments.

Why now: No retained evidence is available within the reviewed sources despite the membership rationale referencing a prior NASA deal article. That makes the name a weak current candidate under local-evidence-only rules.

Caveats: No retained article summary or dated event row is provided for the cited NASA deal. Cannot elevate conviction based only on membership rationale.

180
MBRYONICS Ltd
lowweak
Opp 2
Risk 2

Thesis: The key risk is dependence on indirect role and missing evidence: the reviewed sources does not establish whether MBRYONICS is a prime beneficiary versus a component partner, and no adverse events are documented.

Why now: Why now is weak because only a membership rationale references article about participation in an ESA optical communications project led by Kepler Communications, but no article or reviewed evidence is available for ranking citation.

Caveats: Relation-style partnership context cannot be overused as directional proof. No article is provided for article. Coverage after recent evidence window is empty.